NCT01339871 2017-06-16Study of Pazopanib and Vorinostat in Patients With Advanced MalignanciesM.D. Anderson Cancer CenterPhase 1 Completed152 enrolled
NCT00907738 2015-05-21A Continuation Clinical Trial of Oral Vorinostat (MK-0683) in Advanced Cancers (MK-0683-007)Merck Sharp & Dohme LLCPhase 2 Completed27 enrolled 9 charts